Chemotherapy and Targeted Therapy for Endocrine-Pretreated or Hormone Receptor-Negative Metastatic Breast Cancer and Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: ASCO Guideline Rapid Recommendation Update Q and A

被引：1
|
作者：
Moy, Beverly [1 ]
Wolff, Antonio C. [2 ]
Rumble, R. Bryan [3 ,6 ]
Allison, Kimberly H. [4 ]
Carey, Lisa A. [5 ]
机构：
[1] Massachusetts Gen Hosp, Boston, MA USA
[2] Johns Hopkins Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
[3] Amer Soc Clin Oncol, Alexandria, VA USA
[4] Stanford Univ, Sch Med, Stanford, CA USA
[5] UNC Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA
[6] Amer Soc Clin Oncol, 2318 Mill Rd,Ste 800, Alexandria, VA 22314 USA
来源：
JCO ONCOLOGY PRACTICE | 2023年 / 19卷 / 08期
关键词：
SACITUZUMAB GOVITECAN;
D O I：
10.1200/OP.23.00047
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：547 / +
页数：5
相关论文
共 50 条
  • [1] Chemotherapy and Targeted Therapy for Endocrine-Pretreated or Hormone Receptor-Negative Metastatic Breast Cancer: ASCO Guideline Rapid Recommendation Update
    Moy, Beverly
    Rumble, R. Bryan
    Carey, Lisa A.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (06) : 1318 - +
  • [2] Chemotherapy and Targeted Therapy for Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That Is Either Endocrine-Pretreated or Hormone Receptor-Negative: ASCO Guideline Rapid Recommendation Update
    Moy, Beverly
    Rumble, Bryan
    Carey, Lisa A.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (26) : 3088 - +
  • [3] Chemotherapy and Targeted Therapy for Patients With Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That is Either Endocrine-Pretreated or Hormone Receptor-Negative: ASCO Guideline Update
    Moy, Beverly
    Rumble, R. Bryan
    Come, Steven E.
    Davidson, Nancy E.
    Di Leo, Angelo
    Gralow, Julie R.
    Hortobagyi, Gabriel N.
    Yee, Douglas
    Smith, Ian E.
    Chavez-MacGregor, Mariana
    Nanda, Rita
    McArthur, Heather L.
    Spring, Laura
    Reeder-Hayes, Katherine E.
    Ruddy, Kathryn J.
    Unger, Paul S.
    Vinayak, Shaveta
    Irvin, William J., Jr.
    Armaghani, Avan
    Danso, Michael A.
    Dickson, Natalie
    Turner, Sophie S.
    Perkins, Cheryl L.
    Carey, Lisa A.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (35) : 3938 - +
  • [4] Endocrine Treatment and Targeted Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: ASCO Guideline Update
    Burstein, Harold J.
    Somerfield, Mark R.
    Barton, Debra L.
    Dorris, Ali
    Fallowfield, Lesley J.
    Jain, Dharamvir
    Johnston, Stephen R. D.
    Korde, Larissa A.
    Litton, Jennifer K.
    Macrae, Erin R.
    Peterson, Lindsay L.
    Vikas, Praveen
    Yung, Rachel L.
    Rugo, Hope S.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (35) : 3959 - +
  • [5] Endocrine and Targeted Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer-Capivasertib-Fulvestrant: ASCO Rapid Recommendation Update
    Burstein, Harold J.
    DeMichele, Angela
    Fallowfield, Lesley
    Somerfield, Mark R.
    Henry, N. Lynn
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (12) : 1450 - 1453
  • [6] Testing for ESR1 Mutations to Guide Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: ASCO Guideline Rapid Recommendation Update
    Burstein, Harold
    DeMichele, Angela R.
    Somerfield, Mark
    Henry, N. Lynn
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (18) : 3423 - +
  • [7] Systemic Therapy for Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: ASCO Guideline Update Q and A
    Crews, Jennie R.
    Kirshner, Jeffrey J.
    Temin, Sarah
    JCO ONCOLOGY PRACTICE, 2022, 18 (11) : 753 - +
  • [8] Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: ASCO-College of American Pathologists Guideline Update
    Wolff, Antonio C.
    Somerfield, Mark R.
    Dowsett, Mitchell
    Hammond, M. Elizabeth H.
    Hayes, Daniel F.
    McShane, Lisa M.
    Saphner, Thomas J.
    Spears, Patricia A.
    Allison, Kimberly H.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (22) : 3867 - +
  • [9] Advances in endocrine and targeted therapy for hormone-receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer
    Shen, Le-Sang
    Jin, Xiao-Yan
    Wang, Xu-Meng
    Tou, Lai-Zhen
    Huang, Jian
    CHINESE MEDICAL JOURNAL, 2020, 133 (09) : 1099 - 1108
  • [10] Systemic Therapy for Advanced Human 3 Epidermal Growth Factor Receptor 2-Positive Breast Cancer: ASCO Guideline Update
    Giordano, Sharon H.
    Temin, Sarah
    Chandarlapaty, Sarat
    Crews, Jennie R.
    Kirshner, Jeffrey J.
    Krop, Ian E.
    Lin, Nancy U.
    Patt, Debra A.
    Perlmutter, Jane
    Ramakrishna, Naren
    Davidson, Nancy E.
    Franzoi, Maria Alice B.
    Anders, Carey K.
    Ikawa, Aki
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (23) : 2612 - +
12345